Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Clin Spine Surg ; 35(6): 264-269, 2022 07 01.
Article in English | MEDLINE | ID: mdl-35180720

ABSTRACT

STUDY DESIGN: Retrospective Database Study. OBJECTIVE: Investigate utilization of bone morphogenetic protein (BMP-2) between 2004 and 2014. SUMMARY OF BACKGROUND DATA: The utilization, particularly off-label utilization, of BMP-2 has been controversial and debated in the literature. Given the concerns regarding cancer and potential complications, the risk benefit profile of BMP must be weighed with each surgical case. The debate regarding the costs and potential side effects of BMP-2 compared with autologous iliac crest bone harvest has continued. METHODS: The National Inpatient Sample (NIS) database was queried for the use of BMP-2 (ICD-9-CM 84.52) between 2004 and 2014 across 44 states. The NIS database represents a 20% sample of discharges, weighted to provide national estimates. BMP-2 utilization rates in spine surgery fusion procedures were calculated as a fraction of the total number of thoracic, lumbar, and sacral spinal fusion surgeries performed each year. RESULTS: Between 2004 and 2014, BMP-2 was utilized in 927,275 spinal fusion surgeries. In 2004, BMP-2 was utilized in 28.3% of all cases (N=48,613). The relative use of BMP-2 in spine fusion surgeries peaked in 2008 at 47.0% (N=112,180). Since then, it has continued to steadily decline with an endpoint of 23.6% of cases in 2014 (N=60,863). CONCLUSIONS: Throughout the United States, the utilization of BMP-2 in thoracolumbar fusion surgeries increased from 28.3% to 47.0% between 2004 and 2008. However, from 2008 to 2014, the utilization of BMP-2 in thoracolumbar spine fusion surgeries decreased significantly from 47.0% to 23.4%. While this study provides information on the utilization of BMP-2 for the entire United States over an 11-year period, further research is needed to the determine the factors affecting these trends.


Subject(s)
Bone Morphogenetic Protein 2 , Spinal Fusion , Bone Morphogenetic Protein 2/therapeutic use , Humans , Lumbosacral Region , Retrospective Studies , Spinal Fusion/methods , United States
2.
Anesth Prog ; 61(4): 165-8, 2014.
Article in English | MEDLINE | ID: mdl-25517553

ABSTRACT

IMAGe syndrome (OMIM 300290) is a rare multisystem disorder that has a broad phenotypic presentation. Though variable, this disorder mainly consists of Intrauterine growth retardation, Metaphyseal dysplasia, Adrenal hypoplasia congenita, and Genital abnormalities. Patients with IMAGe syndrome present as an uncommon yet important challenge for dentists and anesthesiologists due to their wide range of dysmorphic facial features, adrenal insufficiency, electrolyte imbalances, and need for steroid replacement. The purpose of this case report is to describe the successful anesthetic management of a pediatric patient diagnosed with IMAGe syndrome who presented for full mouth dental rehabilitation.


Subject(s)
Adrenal Insufficiency/complications , Anesthesia, Dental , Anesthesia, General , Dental Care for Chronically Ill , Mouth Rehabilitation , Osteochondrodysplasias/complications , Urogenital Abnormalities/complications , Anesthetics, Inhalation/administration & dosage , Child, Preschool , Dental Caries/therapy , Dental Prophylaxis , Dental Restoration, Permanent , Female , Fetal Growth Retardation , Gingivitis/therapy , Humans , Intubation, Intratracheal/methods , Periodontal Abscess/therapy , Tooth Extraction , Tooth, Deciduous/pathology
SELECTION OF CITATIONS
SEARCH DETAIL